Health-related Quality of Life and Overall Survival: a Prospective Study in Patients with Head and Neck Cancer Treated with Radiotherapy

Overview

Journal Qual Life Res

Specialties Pharmacology
Rehabilitation Medicine

Date 2020 Dec 8

PMID 33289866

Citations 11

Authors

A J van Nieuwenhuizen

L M Buffart

J A Langendijk

M R Vergeer

J Voortman

C R Leemans

I M Verdonck-de Leeuw

Affiliations

Soon will be listed here.

Abstract

Purpose: We aimed to examine whether pre-treatment, post-treatment and change in health-related quality of Life (HRQoL) is associated with survival, in patients with head and neck cancer (HNC).

Methods: We included 948 newly diagnosed HNC patients treated with primary or adjuvant (chemo)radiotherapy with curative intent. The EORTC QLQ-C30 questionnaire was assessed pre-treatment and at 6 weeks, 6 months and 12 months post-treatment. Multivariable Cox regression analyses were performed to examine whether HRQoL at all time points and changes in HRQoL over time were associated with survival, after adjusting for demographic, clinical and lifestyle-related variables.

Results: Higher HRQoL scores were significantly associated with improved 5-year overall survival at all time points, except for the subscale global QoL at 6 weeks. Changes in HRQoL at 6 weeks post-treatment compared to pre-treatment were not significantly associated with survival. Changes in physical (HR: 0.88 95% CI: 0.82-0.96) and emotional functioning (HR: 0.90 95% CI: 0.85-0.96) from pre-treatment to 6 months post-treatment and changes in global QOL, and physical, emotional, and social functioning from pre-treatment to 12 months post-treatment were significantly associated with survival.

Conclusion: Higher HRQoL reported pre-treatment and post-treatment (6 weeks, 6 months and 12 months) are significantly associated with improved survival, as well as changes in HRQoL at 6 and 12 months compared to pre-treatment. Our results highlight the value of monitoring HRQoL and to identify those patients that report decreased or deteriorated HRQOL. This may help to further improve cancer care in a timely and efficient manner.

Citing Articles

Impact of Face Mask-Wearing on Quality of Life in Post-Surgical Oral Cancer Patients: A Cross-Sectional Study.

Lan R, Silvestri F, Rhanoui M, Bezier C, Fakhry N, Carrouel F Cancers (Basel). 2025; 16(24.

PMID: 39766098 PMC: 11674196. DOI: 10.3390/cancers16244199.

Longitudinal assessment of quality of life indicators and prognosis in esophageal cancer patients with curative resection.

Qiu L, Liang S, Wu L, Huang Y, Yang T, Li C J Thorac Dis. 2024; 16(9):6064-6080.

PMID: 39444865 PMC: 11494538. DOI: 10.21037/jtd-24-311.

Joint modeling of longitudinal health-related quality of life during concurrent chemoradiotherapy period and long-term survival among patients with advanced nasopharyngeal carcinoma.

Li J, Guo S, Liu T, Lin Z, Gong W, Tang L Radiat Oncol. 2024; 19(1):125.

PMID: 39304905 PMC: 11414072. DOI: 10.1186/s13014-024-02473-y.

SOX2 promotes a cancer stem cell-like phenotype and local spreading in oral squamous cell carcinoma.

Sacco A, Battaglia A, Santamaria G, Buffone C, Barone S, Procopio A PLoS One. 2023; 18(12):e0293475.

PMID: 38096163 PMC: 10721099. DOI: 10.1371/journal.pone.0293475.

Factors important for health-related quality of life in men and women: The population based SCAPIS study.

Olsson M, Bjorkelund A, Sandberg J, Blomberg A, Borjesson M, Currow D PLoS One. 2023; 18(11):e0294030.

PMID: 37922283 PMC: 10624288. DOI: 10.1371/journal.pone.0294030.

References

Nordgren M, Hammerlid E, Bjordal K, Ahlner-Elmqvist M, Boysen M, Jannert M . Quality of life in oral carcinoma: a 5-year prospective study. Head Neck. 2007; 30(4):461-70. DOI: 10.1002/hed.20735. View

Oskam I, Verdonck-de Leeuw I, Aaronson N, Kuik D, de Bree R, Doornaert P . Quality of life as predictor of survival: a prospective study on patients treated with combined surgery and radiotherapy for advanced oral and oropharyngeal cancer. Radiother Oncol. 2010; 97(2):258-62. DOI: 10.1016/j.radonc.2010.02.005. View

de Graeff A, de Leeuw J, Ros W, Hordijk G, Blijham G, Winnubst J . Long-term quality of life of patients with head and neck cancer. Laryngoscope. 2000; 110(1):98-106. DOI: 10.1097/00005537-200001000-00018. View

Quinten C, Coens C, Mauer M, Comte S, Sprangers M, Cleeland C . Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncol. 2009; 10(9):865-71. DOI: 10.1016/S1470-2045(09)70200-1. View

Nauta I, Rietbergen M, van Bokhoven A, Bloemena E, Lissenberg-Witte B, Heideman D . Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing. Ann Oncol. 2018; 29(5):1273-1279. DOI: 10.1093/annonc/mdy060. View

Hammerlid E, Bjordal K, Ahlner-Elmqvist M, Boysen M, Evensen J, Biorklund A . A prospective study of quality of life in head and neck cancer patients. Part I: at diagnosis. Laryngoscope. 2001; 111(4 Pt 1):669-80. DOI: 10.1097/00005537-200104000-00021. View

Curran D, Giralt J, Harari P, Ang K, Cohen R, Kies M . Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab. J Clin Oncol. 2007; 25(16):2191-7. DOI: 10.1200/JCO.2006.08.8005. View

Aarstad H, Osthus A, Aarstad H, Lybak S, Aarstad A . General health-related quality of life scores from head and neck squamous cell carcinoma patients obtained throughout the first year following diagnosis predicted up to 10-year overall survival. Eur Arch Otorhinolaryngol. 2017; 275(1):207-217. DOI: 10.1007/s00405-017-4800-8. View

Abendstein H, Nordgren M, Boysen M, Jannert M, Silander E, Ahlner-Elmqvist M . Quality of life and head and neck cancer: a 5 year prospective study. Laryngoscope. 2005; 115(12):2183-92. DOI: 10.1097/01.MLG.0000181507.69620.14. View

10.

Thompson T, Pagedar N, Karnell L, Funk G . Factors associated with mortality in 2-year survivors of head and neck cancer. Arch Otolaryngol Head Neck Surg. 2011; 137(11):1100-5. DOI: 10.1001/archoto.2011.179. View

11.

Goldstein D, Karnell L, Christensen A, Funk G . Health-related quality of life profiles based on survivorship status for head and neck cancer patients. Head Neck. 2006; 29(3):221-9. DOI: 10.1002/hed.20507. View

12.

Mol L, Ottevanger P, Koopman M, Punt C . The prognostic value of WHO performance status in relation to quality of life in advanced colorectal cancer patients. Eur J Cancer. 2016; 66:138-43. DOI: 10.1016/j.ejca.2016.07.013. View

13.

Funk G, Karnell L, Christensen A . Long-term health-related quality of life in survivors of head and neck cancer. Arch Otolaryngol Head Neck Surg. 2012; 138(2):123-33. DOI: 10.1001/archoto.2011.234. View

14.

van Nieuwenhuizen A, Buffart L, Brug J, Leemans C, Verdonck-de Leeuw I . The association between health related quality of life and survival in patients with head and neck cancer: a systematic review. Oral Oncol. 2014; 51(1):1-11. DOI: 10.1016/j.oraloncology.2014.09.002. View

15.

Siddiqui F, Pajak T, Watkins-Bruner D, Konski A, Coyne J, Gwede C . Pretreatment quality of life predicts for locoregional control in head and neck cancer patients: a radiation therapy oncology group analysis. Int J Radiat Oncol Biol Phys. 2007; 70(2):353-60. DOI: 10.1016/j.ijrobp.2007.06.024. View

16.

Osoba D, Rodrigues G, Myles J, Zee B, Pater J . Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998; 16(1):139-44. DOI: 10.1200/JCO.1998.16.1.139. View

17.

Bjordal K, Ahlner-Elmqvist M, Tollesson E, Jensen A, Razavi D, Maher E . Development of a European Organization for Research and Treatment of Cancer (EORTC) questionnaire module to be used in quality of life assessments in head and neck cancer patients. EORTC Quality of Life Study Group. Acta Oncol. 1994; 33(8):879-85. DOI: 10.3109/02841869409098450. View

18.

Lango M, Egleston B, Fang C, Burtness B, Galloway T, Liu J . Baseline health perceptions, dysphagia, and survival in patients with head and neck cancer. Cancer. 2013; 120(6):840-7. PMC: 3951722. DOI: 10.1002/cncr.28482. View

19.

Coyne J, Pajak T, Harris J, Konski A, Movsas B, Ang K . Emotional well-being does not predict survival in head and neck cancer patients: a Radiation Therapy Oncology Group study. Cancer. 2007; 110(11):2568-75. DOI: 10.1002/cncr.23080. View

20.

Quinten C, Martinelli F, Coens C, Sprangers M, Ringash J, Gotay C . A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites. Cancer. 2013; 120(2):302-11. DOI: 10.1002/cncr.28382. View